Conversation Therapy for Aphasia
What You Need to Know Before You Apply
What is the purpose of this trial?
This trial tests a conversation therapy designed to assist individuals with aphasia, a condition affecting speech and communication, often due to a stroke. Researchers are examining whether group characteristics, such as size and composition, along with the severity of aphasia, influence the effectiveness of this therapy. Participants will engage in guided discussions on everyday topics to enhance communication skills. The trial seeks native English speakers who experienced a stroke at least six months ago and have been diagnosed with aphasia, without other serious medical conditions. As an unphased trial, it offers participants the chance to contribute to innovative research that could improve therapy options for aphasia.
Do I have to stop taking my current medications for the trial?
The trial protocol does not specify whether you need to stop taking your current medications. However, you must abstain from any concurrent speech language treatment.
Will I have to stop taking my current medications?
The trial protocol does not specify whether you need to stop taking your current medications. However, you will need to stop any concurrent speech language treatment while participating in the trial.
What prior data suggests that this conversation therapy is safe for people with aphasia?
Research has shown that conversation therapy for aphasia is generally safe and well-tolerated. In one study with 24 adults who had long-term aphasia, participants in group communication sessions showed significant improvements. No serious side effects were reported, indicating the treatment's safety for people with aphasia.
The therapy involves group sessions where participants discuss everyday topics like current events or travel. It aims to improve communication skills and is designed to be practical and supportive for everyone involved.
Some studies have also examined online versions of this therapy and found them easy to use, with participants reporting high satisfaction. This supports the idea that conversation therapy is a safe and promising option for those seeking to improve their speech and communication skills.12345Why are researchers excited about this trial?
Researchers are excited about Conversation Therapy for Aphasia because it explores the impact of group dynamics on treatment outcomes, which is a fresh angle in aphasia rehabilitation. Traditional aphasia therapies often focus on one-on-one speech therapy sessions, but this approach looks at how group size and composition—like pairing individuals with similar or varying severities—can influence recovery. By investigating these variables, the trial aims to uncover more personalized and potentially more effective ways to improve communication skills in people with aphasia, offering hope for tailored interventions that go beyond standard care.
What evidence suggests that this trial's treatments could be effective for aphasia?
Research shows that conversation treatment can greatly improve communication for people with aphasia. Studies have found that group conversation sessions enhance language skills and quality of life. This trial will explore different approaches to conversation treatment. One arm will assess the treatment's efficacy in a delayed control group. Another arm will examine outcomes based on group size and aphasia severity, comparing large groups to dyads. A third arm will evaluate outcomes based on group composition, comparing homogeneous to heterogeneous groups. Although benefits can vary with group size, composition, and aphasia severity, the overall approach has shown positive results.23678
Who Is on the Research Team?
Elizabeth Hoover, PhD
Principal Investigator
Boston University
Gayle DeDe, PhD
Principal Investigator
Temple University
Are You a Good Fit for This Trial?
This trial is for English-speaking adults with aphasia, a language disorder typically caused by stroke. They must be at least 6 months post-stroke and have enough understanding to join in conversations. The study includes all severity levels of aphasia but excludes those with other neurological diseases, developmental disabilities, or serious illnesses like cancer.Inclusion Criteria
Exclusion Criteria
Timeline for a Trial Participant
Screening
Participants are screened for eligibility to participate in the trial
Treatment
Participants receive conversation group treatment for aphasia in either large groups or dyads, facilitated by a speech pathologist focusing on everyday topics.
Follow-up
Participants are monitored for changes in communication ability using the Aphasia Communication Outcome Measure and Comprehensive Aphasia Test.
What Are the Treatments Tested in This Trial?
Interventions
- Conversation Treatment for Aphasia
Conversation Treatment for Aphasia is already approved in United States, European Union for the following indications:
- Aphasia
- Aphasia
- Stroke-related Aphasia
Find a Clinic Near You
Who Is Running the Clinical Trial?
Boston University Charles River Campus
Lead Sponsor
Temple University
Collaborator
Adler Aphasia Center
Collaborator